Vivo Opportunity Fund Ups Soleno Stake to 10.8%

TL;DR

Vivo Opportunity Fund now owns 10.8% of Soleno Therapeutics after filing an amendment. Big player watching closely.

AI Summary

Vivo Opportunity Fund Holdings, L.P. filed an amendment (No. 2) to its Schedule 13D on May 1, 2024, regarding its holdings in Soleno Therapeutics, Inc. The filing indicates a change in beneficial ownership, with Vivo Opportunity Fund Holdings, L.P. now holding 10.8% of the outstanding common stock, amounting to 2,437,500 shares. This filing follows a previous amendment and reflects ongoing activity related to their investment in Soleno Therapeutics.

Why It Matters

This filing signals a significant ownership stake by Vivo Opportunity Fund in Soleno Therapeutics, potentially influencing corporate strategy or future transactions.

Risk Assessment

Risk Level: medium — Changes in significant beneficial ownership can indicate shifts in investor sentiment or strategy, which may impact the stock price.

Key Numbers

• 10.8% — Ownership Stake (Vivo Opportunity Fund's beneficial ownership percentage in Soleno Therapeutics as of May 1, 2024.)
• 2,437,500 — Shares Held (The total number of Soleno Therapeutics common shares held by Vivo Opportunity Fund.)

Key Players & Entities

• Vivo Opportunity Fund Holdings, L.P. (company) — Filing entity
• Soleno Therapeutics, Inc. (company) — Subject company
• Kevin Dai (person) — Authorized to receive notices
• 2,437,500 (dollar_amount) — Number of shares held
• 10.8% (dollar_amount) — Percentage of shares held

FAQ

Key Financial Figures

• $0.001 — ame of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• ea0205094-13da2vivo_soleno.htm (SC 13D/A) — 47KB
• 0001213900-24-038340.txt ( ) — 48KB

PURPOSE OF TRANSACTION

ITEM 4. PURPOSE OF TRANSACTION Vivo Opportunity Fund Holdings, L.P. sold 750,000 and 351,242 shares of Common Stock of the Issuer on April 29 and April 30, 2024, respectively. The aggregate number of shares of Common Stock sold by Opportunity Fund Holdings, L.P. on the two days is 1,101,242.

INTEREST IN SECURITIES OF THE ISSUER

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER (a)-(b) The information set forth in rows 7 through 13 of the cover pages and Item 4 of this Schedule 13D is incorporated by reference into this Item 5. The percent of class was calculated based upon 32,460,579 shares of Common Stock of the Issuer outstanding as of March 1, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 7, 2024. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., and may be deemed to beneficially own the shares of Common Stock held directly by Vivo Opportunity Fund Holdings, L.P. (c) Except as described in Item 4 hereof, none of the Reporting Persons has effected any transaction of the Issuer’s Common Stock in the last 60 days. (d) Not Applicable. (e) Not Applicable. 4 SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this Statement is true, complete and correct. Dated: May 1, 2024 VIVO OPPORTUNITY FUND HOLDINGS, L.P, By: Vivo Opportunity, LLC /s/ Kevin Dai Name: Kevin Dai Title: Managing Member VIVO OPPORTUNITY, LLC /s/ Kevin Dai Name: Kevin Dai Title: Managing Member 5